Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization.

PubWeight™: 1.25‹?› | Rank: Top 10%

🔗 View Article (PMC 240580)

Published in J Virol on May 01, 1991

Authors

A Larose1, N Dyson, M Sullivan, E Harlow, M Bastin

Author Affiliations

1: Department of Microbiology, University of Sherbrooke, Quebec, Canada.

Articles citing this

The ability of simian virus 40 large T antigen to immortalize primary mouse embryo fibroblasts cosegregates with its ability to bind to p53. J Virol (1991) 1.46

A novel Rb- and p300-binding protein inhibits transactivation by MyoD. Mol Cell Biol (2000) 1.40

The DnaJ domain of polyomavirus large T antigen is required to regulate Rb family tumor suppressor function. J Virol (1997) 1.21

Coevolution of persistently infecting small DNA viruses and their hosts linked to host-interactive regulatory domains. Proc Natl Acad Sci U S A (1993) 1.16

Tiny T antigen: an autonomous polyomavirus T antigen amino-terminal domain. J Virol (1997) 1.10

Coordinated trans activation of DNA synthesis- and precursor-producing enzymes by polyomavirus large T antigen through interaction with the retinoblastoma protein. Mol Cell Biol (1994) 1.05

Identification of TAZ as a binding partner of the polyomavirus T antigens. J Virol (2004) 1.05

Protein domains connect cell cycle stimulation directly to initiation of DNA replication. Proc Natl Acad Sci U S A (1994) 1.02

The p110alpha isoform of phosphatidylinositol 3-kinase is essential for polyomavirus middle T antigen-mediated transformation. J Virol (2007) 1.01

Polyomavirus large and small T antigens cooperate in induction of the S phase in serum-starved 3T3 mouse fibroblasts. J Virol (1992) 0.97

Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation. J Virol (1993) 0.95

Polyomavirus large T antigen induces alterations in cytoplasmic signalling pathways involving Shc activation. J Virol (1999) 0.94

J domain-independent regulation of the Rb family by polyomavirus large T antigen. J Virol (2000) 0.94

Host range and cell cycle activation properties of polyomavirus large T-antigen mutants defective in pRB binding. J Virol (1994) 0.93

Characterization of an immortalizing N-terminal domain of polyomavirus large T antigen. J Virol (1994) 0.92

Stimulation of DNA replication from the polyomavirus origin by PCAF and GCN5 acetyltransferases: acetylation of large T antigen. Mol Cell Biol (2002) 0.90

The activity of differentiation factors induces apoptosis in polyomavirus large T-expressing myoblasts. Mol Biol Cell (1998) 0.89

Zinc-binding and protein-protein interactions mediated by the polyomavirus large T antigen zinc finger. J Virol (1995) 0.89

Transformation and tumorigenic properties of a mutant polyomavirus containing a middle T antigen defective in Shc binding. J Virol (1997) 0.88

Complex formation between the lymphotropic papovavirus large tumor antigen and the tumor suppressor protein p53. J Virol (1991) 0.88

High-frequency recombination mediated by polyomavirus large T antigen defective in replication. J Virol (1993) 0.87

Phosphorylation sites in polyomavirus large T antigen that regulate its function in viral, but not cellular, DNA synthesis. J Virol (1997) 0.86

Amplification mediated by polyomavirus large T antigen defective in replication. J Virol (1993) 0.85

Activation of CREB/ATF sites by polyomavirus large T antigen. J Virol (2005) 0.84

Genetic analysis of polyomavirus large T nuclear localization: nuclear localization is required for productive association with pRb family members. J Virol (1996) 0.84

Polyoma virus-induced osteosarcomas in inbred strains of mice: host determinants of metastasis. PLoS Pathog (2010) 0.84

Cyclin-dependent kinase regulation of the replication functions of polyomavirus large T antigen. J Virol (1997) 0.84

The retinoblastoma protein alters the phosphorylation state of polyomavirus large T antigen in murine cell extracts and inhibits polyomavirus origin DNA replication. J Virol (1999) 0.83

Functional implications of mutations within polyomavirus large T antigen Rb-binding domain: effects on pRb and p107 binding in vitro and immortalization activity in vivo. J Virol (1996) 0.82

Necdin, a p53-target gene, is an inhibitor of p53-mediated growth arrest. PLoS One (2012) 0.81

Effect on polyomavirus T-antigen function of mutations in a conserved leucine-rich segment of the DnaJ domain. J Virol (2001) 0.80

Importance of the Ser-132 phosphorylation site in cell transformation and apoptosis induced by the adenovirus type 5 E1A protein. J Virol (1996) 0.80

Primary rat cells expressing a hybrid polyomavirus-simian virus 40 large T antigen have altered growth properties. J Virol (1993) 0.78

E1A 12S and 13S of the transformation-defective adenovirus type 12 strain CS-1 inactivate proteins of the RB family, permitting transactivation of the E2F-dependent promoter. J Virol (1997) 0.75

Articles cited by this

New M13 vectors for cloning. Methods Enzymol (1983) 90.74

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (1983) 19.76

Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors. Methods Enzymol (1983) 17.47

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (1986) 13.96

Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science (1990) 12.88

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell (1988) 12.69

The p53 proto-oncogene can act as a suppressor of transformation. Cell (1989) 11.67

Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (1988) 10.98

Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell (1982) 9.27

New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol (1984) 8.63

Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J (1989) 7.69

Cellular targets for transformation by the adenovirus E1A proteins. Cell (1989) 7.53

Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science (1987) 6.93

Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein. Nature (1981) 6.70

Structural evidence for the authenticity of the human retinoblastoma gene. Science (1987) 4.67

The roles of individual polyoma virus early proteins in oncogenic transformation. Nature (1982) 4.57

An adenovirus E1a protein region required for transformation and transcriptional repression. Cell (1986) 4.56

Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science (1988) 4.26

Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol Cell Biol (1986) 4.14

Expression of the large T protein of polyoma virus promotes the establishment in culture of "normal" rodent fibroblast cell lines. Proc Natl Acad Sci U S A (1983) 3.65

In vitro mutagenesis of a putative DNA binding domain of SV40 large-T. Virology (1984) 3.50

Mapping of cellular protein-binding sites on the products of early-region 1A of human adenovirus type 5. Mol Cell Biol (1988) 3.07

Substrate specificity determinants for casein kinase II as deduced from studies with synthetic peptides. J Biol Chem (1987) 3.04

Two regions of the adenovirus early region 1A proteins are required for transformation. J Virol (1988) 3.02

A point mutational analysis of human papillomavirus type 16 E7 protein. J Virol (1989) 3.00

The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell (1989) 2.98

Detection of cellular proteins associated with human adenovirus type 5 early region 1A polypeptides. Virology (1985) 2.80

An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein, p120. Cell (1989) 2.78

Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J Virol (1990) 2.40

Fragments of the simian virus 40 transforming gene facilitate transformation of rat embryo cells. Proc Natl Acad Sci U S A (1982) 2.29

The protein products of the myc and myb oncogenes and adenovirus E1a are structurally related. Nature (1984) 2.25

Immortalization of primary rat cells by human papillomavirus type 16 subgenomic DNA fragments controlled by the SV40 promoter. Virology (1988) 2.11

Cell lines established by a temperature-sensitive simian virus 40 large-T-antigen gene are growth restricted at the nonpermissive temperature. Mol Cell Biol (1989) 2.04

Construction and functional characterization of polyomavirus genomes that separately encode the three early proteins. J Virol (1984) 2.02

A region of SV40 large T antigen can substitute for a transforming domain of the adenovirus E1A products. Nature (1988) 2.01

The large tumor antigen of simian virus 40 encodes at least two distinct transforming functions. J Virol (1989) 2.00

Endothelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogene. Cell (1987) 1.87

Large T antigens of simian virus 40 and polyomavirus efficiently establish primary fibroblasts. J Virol (1986) 1.83

A fragment of the SV40 large T-antigen gene transforms. Nature (1982) 1.82

Prediction of similar transforming regions in simian virus 40 large T, adenovirus E1A, and myc oncoproteins. J Virol (1988) 1.63

Characterization of the in vitro interaction between SV40 T antigen and p53: mapping the p53 binding site. Virology (1988) 1.56

DNA sequences of polyoma virus early deletion mutants. J Virol (1981) 1.51

Identification of a region of simian virus 40 large T antigen required for cell transformation. J Virol (1990) 1.50

Role of the three polyoma virus early proteins in tumorigenesis. Mol Cell Biol (1983) 1.40

Sequences from polyomavirus and simian virus 40 large T genes capable of immortalizing primary rat embryo fibroblasts. J Virol (1985) 1.31

Loss of a highly conserved domain on p53 as a result of gene deletion during Friend virus-induced erythroleukemia. Oncogene (1988) 1.28

Integration of Friend murine leukemia virus into both alleles of the p53 oncogene in an erythroleukemic cell line. J Virol (1988) 1.10

Immortalization of rat embryo fibroblasts by mutant polyomavirus large T antigens deficient in DNA binding. Mol Cell Biol (1986) 1.08

Mutation in the polyomavirus genome that activates the properties of large T associated with neoplastic transformation. J Virol (1986) 0.96

Mutations in polyomavirus large T affecting immortalization of primary rat embryo fibroblasts. Virology (1990) 0.90

Articles by these authors

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54

Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol (1981) 15.59

Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (1988) 10.98

Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 10.03

Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults. JAMA (2000) 8.15

Distinct roles for cyclin-dependent kinases in cell cycle control. Science (1993) 8.13

Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J (1989) 7.69

Cellular targets for transformation by the adenovirus E1A proteins. Cell (1989) 7.53

New functional activities for the p21 family of CDK inhibitors. Genes Dev (1997) 6.97

The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell (1989) 6.68

A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell (1992) 6.32

Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products. J Virol (1985) 5.69

Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev (1993) 5.54

Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol (1994) 5.18

Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol (1998) 5.15

A family of human cdc2-related protein kinases. EMBO J (1992) 4.96

Association of a murine 53,000-dalton phosphoprotein with simian virus 40 large-T antigen in transformed cells. J Virol (1980) 4.88

Tumor induction and tissue atrophy in mice lacking E2F-1. Cell (1996) 4.80

Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions. Proc Natl Acad Sci U S A (1996) 4.70

Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase. Nature (1991) 4.36

pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev (1997) 4.36

Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature (1992) 4.21

Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev (1993) 4.14

Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol Cell Biol (1986) 4.14

Intervening sequence of DNA identified in the structural portion of a mouse beta-globin gene. Proc Natl Acad Sci U S A (1978) 4.02

Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev (1992) 3.96

p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature (1994) 3.95

The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol (1993) 3.75

RNA folding at millisecond intervals by synchrotron hydroxyl radical footprinting. Science (1998) 3.67

Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev (1996) 3.61

Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol (1993) 3.54

Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev (1994) 3.47

The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer (1994) 3.45

Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature (1995) 3.41

The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.40

Examining associations between childhood asthma and traffic flow using a geographic information system. Environ Health Perspect (1999) 3.39

Point mutational inactivation of the retinoblastoma antioncogene. Science (1989) 3.37

The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.37

Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc Natl Acad Sci U S A (1998) 3.27

Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years. J Fam Pract (2001) 3.21

Structures of two spliced herpes simplex virus type 1 immediate-early mRNA's which map at the junctions of the unique and reiterated regions of the virus DNA S component. J Virol (1981) 3.19

The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J (1991) 3.15

Improving collaboration between researchers and communities. Public Health Rep (2000) 3.13

Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Mol Cell Biol (1985) 3.09

A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells. Cell (1989) 3.08

Two regions of the adenovirus early region 1A proteins are required for transformation. J Virol (1988) 3.02

The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene (1993) 2.99

Cloning of integrated Moloney sarcoma proviral DNA sequences in bacteriophage lambda. Proc Natl Acad Sci U S A (1979) 2.98

The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell (1989) 2.98

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology (2004) 2.97

Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol (1992) 2.97

Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes (Lond) (2007) 2.95

RBF, a novel RB-related gene that regulates E2F activity and interacts with cyclin E in Drosophila. Genes Dev (1996) 2.92

NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev (2000) 2.90

Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med (1993) 2.81

The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J (1990) 2.80

Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature (1991) 2.78

Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev (1996) 2.71

Psychometric properties and factor structure of the Three-Factor Eating Questionnaire (TFEQ) in obese men and women. Results from the Swedish Obese Subjects (SOS) study. Int J Obes Relat Metab Disord (2000) 2.67

p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev (1995) 2.60

The transcription factor E2F is required for S phase during Drosophila embryogenesis. Genes Dev (1995) 2.60

Complex of simian virus 40 large-T antigen and host 53,000-molecular-weight protein in monkey cells. J Virol (1981) 2.60

Dispelling the stigma of schizophrenia: what sort of information is best? Schizophr Bull (1994) 2.53

Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice. Nat Genet (1998) 2.53

pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc Natl Acad Sci U S A (1998) 2.49

Nuclear organization of DNA replication in primary mammalian cells. Genes Dev (2000) 2.48

Hydrogen-poor superluminous stellar explosions. Nature (2011) 2.48

Structure of the human interleukin-2 receptor gene. Science (1985) 2.43

Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J Virol (1990) 2.40

Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins. Science (1992) 2.39

Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells. Nature (1984) 2.36

Comparison of circumsporozoite proteins from avian and mammalian malarias: biological and phylogenetic implications. Proc Natl Acad Sci U S A (1996) 2.35

Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens. N Engl J Med (2001) 2.32

Adenovirus E1A targets key regulators of cell proliferation. Cancer Surv (1992) 2.29

Polyomavirus small t antigen: overproduction in bacteria, purification, and utilization for monoclonal and polyclonal antibody production. J Virol (1986) 2.27

Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.22

Evaluating translations of health status questionnaires. Methods from the IQOLA project. International Quality of Life Assessment. Int J Technol Assess Health Care (1995) 2.22

Characterization of the retinoblastoma binding proteins RBP1 and RBP2. Oncogene (1993) 2.20

A poliovirus replicon containing the chloramphenicol acetyltransferase gene can be used to study the replication and encapsidation of poliovirus RNA. J Virol (1992) 2.20

Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides. Mol Cell Biol (1991) 2.20

Isolation and characterization of overlapping genomic clones covering the chicken alpha 2 (type I) collagen gene. Proc Natl Acad Sci U S A (1980) 2.18

Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. Genes Dev (1998) 2.14

RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest. Mol Cell Biol (2001) 2.14

Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science (1992) 2.13

Swedish obese subjects (SOS)--an intervention study of obesity. Two-year follow-up of health-related quality of life (HRQL) and eating behavior after gastric surgery for severe obesity. Int J Obes Relat Metab Disord (1998) 2.11

Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development (1993) 2.09

DNA-binding and trans-activation properties of Drosophila E2F and DP proteins. Proc Natl Acad Sci U S A (1994) 2.08

Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.05

Do SF-36 summary component scores accurately summarize subscale scores? Qual Life Res (2001) 2.05